Yes, Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with a BMI of 30 kg/m or higher, or 27 kg/m or higher with at least one weight-related comorbidity such as hypertension or dyslipidemia
Originally developed for managing blood sugar, this FDA-approved therapy has shown remarkable results in helping people shed pounds by curbing appetite and promoting a sense of fullness
Polls reveal that one in five Americans has skipped prescriptions due to cost, while many substituted with supplements
If side effects are significant even at this dose, it may indicate the need for a slower escalation plan
Key Features: Advanced Fat Metabolism Support Combines CLA, green tea extract, and L-carnitine to promote fat burning and efficient energy conversion during exercise
Practical considerations for getting started If you and your healthcare provider decide that GLP-1 microdosing is worth exploring for your autoimmune condition, here are the practical details that matter